Asgard Therapeutics AB
559184-0136ActivePioneering in vivo cell reprogramming for next-generation cancer immunotherapy.
Yleiskatsaus
- 10–19
- Työntekijät
- ≤1t SEK
- Liikevaihto
- 2018
- Perustettu
Avainpäättäjät
Cristiana Pires
Co-founder and CEO
Fábio Rosa
Co-founder and VP of Research
Alexey Zeifman
Board Member
Philipp Müller
Board Member
+26 lisää yhteystietoja Funnelfeedrissä
Kuvaus
Asgard Therapeutics is a Swedish private biotech company focused on revolutionizing cancer immunotherapy. Their core mission involves pioneering direct cell reprogramming technologies. Specifically, they aim to develop scalable methods for the in vivo conversion of cancer cells into functional antig...
Tunnisteet
Avainsanat
Teknologiat
Yritystiedot
- Toimiala
- Bioteknisk forskning och utveckling
- Oikeudellinen muoto
- Aktiebolag
- ALV-numero
- SE559184013601
Päättäjät
30 yhteystietoa FunnelfeedrissäCristiana Pires
Co-founder and CEO
Fábio Rosa
Co-founder and VP of Research
Alexey Zeifman
Board Member
Philipp Müller
Board Member
Nadiya Ishnazarova
Board Member
Xiaoli Huang
Project Director Preclinical Pharmacology
Ignacio Melero
Advisory Board Member
Johanna Olweus
Scientific Advisory Board Member
Shane Olwill
Chief Development Officer
João Ribas
Board Member
Jan Villadsen
Head of Finance
Ulrich Lauer
Advisory Board Member
Jonas Jendi
Board Member
Martin Bonde
Chair of the Board
Joshua Brody
Advisory Board Member
Fiona MacLaughlin
Board Member (Johnson & Johnson Innovation – JJDC, Inc.)
Brian Brown
Advisory Board Member
Aleksei Zeifman
Board Member (RV Invest)
Filipe Pereira
Co-founder and Head of Innovation
Frank Hennecke
Head of CMC
Wolfram Brugger
Chief Medical Officer
Aurélien Marabelle
Advisory Board Member
Cristina Csimma
Independent Board Member
Julie M Cherrington
Advisory Board Member
Muut yhteyshenkilöt
Iveta Mikalajūnaitė
Team Member
Xavier Catena
Team Member
Emilie Renaud
Team Member
André Rosa
Team Member
+2 lisää yhteystietoja Funnelfeedrissä
Samankaltaiset yritykset
20 samankaltaista yritystä FunnelfeedrissäSACRA Therapeutics AB
0 työntekijätSACRA pioneers novel RNA-targeting therapies for incurable cancers.
Anocca AB
100–199 työntekijätEngineering precision T-cell immunotherapies for hard-to-treat cancers.
Lokon Pharma AB
10–19 työntekijätDeveloping novel gene engineering vectors for cancer immunotherapy.
Valo Therapeutics Oy
Developing novel peptide-coated oncolytic virus immunotherapies for cancer.
Theralia AB
0 työntekijätPioneering biotech revolutionizing drug delivery via TOUCAN technology.
Selaa lisää
Kysymyksiä yrityksestä Asgard Therapeutics AB
Haluatko nähdä Funnelfeedrin toiminnassa?
Varaa ilmainen demo ja tutustu siihen, miten Funnelfeedr auttaa sinua löytämään ja konvertoimaan ihanteelliset asiakkaasi.
Varaa demo